Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug tested to speed recovery from paralyzing nerve disorder

NCT ID NCT04752566

Completed Disease control Sponsor: Alexion Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding the drug eculizumab to standard treatment helps people with severe Guillain-Barré Syndrome (GBS) recover faster. GBS is a serious condition where the immune system attacks the nerves, causing muscle weakness and sometimes paralysis. The trial involved 57 participants in Japan who could not walk unaided and were randomly assigned to receive either eculizumab or a placebo, in addition to standard immunoglobulin therapy, to see which group regained mobility more quickly.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GUILLAIN-BARRE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Bunkyō City, 113-8519, Japan

  • Research Site

    Chiba, 260-0877, Japan

  • Research Site

    Fukuoka, 814-0180, Japan

  • Research Site

    Hiroshima, 730-8518, Japan

  • Research Site

    Kagoshima, 890-8520, Japan

  • Research Site

    Kawagoe-shi, 350-8550, Japan

  • Research Site

    Kawasaki-shi, 216-8511, Japan

  • Research Site

    Kitakyushu-shi, 807-8555, Japan

  • Research Site

    Kobe, 650-0047, Japan

  • Research Site

    Kumamoto, 860-8556, Japan

  • Research Site

    Kurashiki-shi, 710-8602, Japan

  • Research Site

    Matsumoto-shi, 390-8621, Japan

  • Research Site

    Mitaka-shi, 181-8611, Japan

  • Research Site

    Nagoya, 466-8560, Japan

  • Research Site

    Niigata, 951-8520, Japan

  • Research Site

    Nishinomiya-shi, 663-8501, Japan

  • Research Site

    Sapporo, 060-8648, Japan

  • Research Site

    Sayama, 589-8511, Japan

  • Research Site

    Sendai, 983-8520, Japan

  • Research Site

    Shimotsuga-gun, 321-0293, Japan

  • Research Site

    Ube-shi, 755-8505, Japan

  • Research Site

    Yokohama, 236-0004, Japan

Conditions

Explore the condition pages connected to this study.

GUILLAIN-BARRE SYNDROME